Sarepta Therapeutics and Catalent sign manufacturing deal for DMD gene therapy approval
January 9, 2023Manufacturing and Production
Sarepta Therapeutics is a company focused on gene therapy, RNA and gene editing, engineering precision genetic medication for rare diseases. …
James Noble
January 6, 2023Business Services
St Andrews, UK – 6 January 2023 – Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal …
Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration
January 6, 2023Business Services
Strasbourg, France, January 6, 2023, 7:30 a.m.
Sanofi plans eco-friendly additions to Brisbane manufacturing campus
January 6, 2023Manufacturing and Production
Sanofi is aiming to expand its eco-friendly and renewable energy ecosystem with plans to install solar panels on the carpark, …
Moderna agrees first acquisition for $85m
January 6, 2023Sales and Marketing
After a pivotal few years, Moderna has agreed its first acquisition, worth $85m, which will allow the company access to …
BioNTech and UK Government announce strategic partnership to provide mRNA cancer immunotherapies
January 6, 2023Medical Communications
German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU) which will accelerate clinical trials …
Withings announces hands-free connected in-home urine lab
January 6, 2023Medical Communications
Connected health firm Withings has unveiled its new in-home biomarker analysis platform U-Scan. It is hoped the device will utilise …
Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs
January 5, 2023Medical Communications
AMSTERDAM, THE NETHERLANDS, 5 January 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for …
Nouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal Cancer
January 5, 2023Business Services
BASEL, Switzerland – 5th January 2023 – Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, today announced …
Lidia Oostvogels
January 5, 2023Business Services
MinervaX appoints Lidia Oostvogels as Chief Medical Officer and provides clinical and regulatory update on its novel GBS vaccine
iOnctura provides development update on first-in-class semi-allosteric PI3Kδ inhibitor program
January 5, 2023Business Services
Geneva, Switzerland and Amsterdam, The Netherlands, 5 January – iOnctura, a clinical-stage biotech developing selective cancer therapies against targets that …
Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform
January 5, 2023Business Services
Copenhagen, Denmark, January 5, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …
Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders
January 5, 2023Business Services
Tokyo, Japan and Cambridge, UK, 5 January 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
FDA accepts application for nirsevimab as first protective option for RSV in infants
January 5, 2023Medical Communications
The FDA has accepted an application for nirsevimab as the first protective option to combat respiratory syncytial virus (RSV) disease …
Island Pharmaceuticals to begin phase 2 trial for dengue prevention and treatment drug
January 5, 2023Research and Development
It is possible that Island Pharmaceuticals could begin its phase 2a PEACH clinical trial as soon as January 2023. The …
Belharra Therapeutics and Genentech join forces for small molecule medicine development
January 5, 2023Research and Development
US-based biotech companies Belharra Therapeutics and Genentech have announced a multi-year partnership to lead the discovery and development of small …
Biogen and Alcyone Therapeutics enter partnership to develop ThecaFlex DRx system for ASO therapies
January 5, 2023Research and Development
US-based Biogen and Alcyone Therapeutics have entered into a license and collaboration agreement to develop Alcyone’s ThecaFlex DRx™ System. …
Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program
January 4, 2023Business Services
Amsterdam and San Francisco / Houston / Singapore, 4 January 2023 — Synaffix B.V.
ISA Pharmaceuticals and Cancer Focus Fund Announce $5 Million Investment to Support First-in-Human Trial of ISA’s Novel Immunotherapy ISA103 in Uveal Melanoma
January 4, 2023Business Services
Oegstgeest, Netherlands and Houston, Texas, January 4, 2023 – ISA Pharmaceuticals, B.V., a clinical stage biotech company developing immunotherapies to …
Dr Samson Fung
January 4, 2023Business Services
Molecure Appoints Dr. Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
